GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Merck KGaA (OTCPK:MKGAF) » Definitions » Other Long-Term Liabilities

MKGAF (Merck KGaA) Other Long-Term Liabilities : $1,323 Mil (As of Mar. 2025)


View and export this data going back to 2013. Start your Free Trial

What is Merck KGaA Other Long-Term Liabilities?

Merck KGaA's other long-term liabilities for the quarter that ended in Mar. 2025 was $1,323 Mil.

Merck KGaA's quarterly other long-term liabilities declined from Sep. 2024 ($1,437 Mil) to Dec. 2024 ($1,356 Mil) and declined from Dec. 2024 ($1,356 Mil) to Mar. 2025 ($1,323 Mil).

Merck KGaA's annual other long-term liabilities declined from Dec. 2022 ($1,851 Mil) to Dec. 2023 ($1,712 Mil) and declined from Dec. 2023 ($1,712 Mil) to Dec. 2024 ($1,356 Mil).


Merck KGaA Other Long-Term Liabilities Historical Data

The historical data trend for Merck KGaA's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Merck KGaA Other Long-Term Liabilities Chart

Merck KGaA Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,283.46 2,032.77 1,850.63 1,712.11 1,356.02

Merck KGaA Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,626.09 1,509.15 1,437.29 1,356.02 1,323.24

Merck KGaA Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.


Merck KGaA Other Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Merck KGaA's Other Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Merck KGaA Business Description

Address
Frankfurter Strasse 250, Darmstadt, HE, DEU, 64293
Merck KGaA operates in three main segments: Life Science, Electronics, and Healthcare. The Life Science segment provides laboratory consumables and instruments to researchers in academia and applied fields, including the biopharmaceutical industry. The Electronics segment offers specialty materials to manufacture a variety of products, such as semiconductors and flat-screen televisions. In the healthcare segment, Merck develops, manufactures, and sells branded pharmaceuticals with significant therapeutic concentrations in oncology, multiple sclerosis, and fertility. In 1995, the E. Merck KG family publicly sold part of the company, resulting in the current 30% public ownership of the firm.

Merck KGaA Headlines

From GuruFocus

Q1 2024 Merck KGaA Earnings Call Transcript

By GuruFocus Research 05-16-2024

Merck KGaA R&D Update Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024

Full Year 2021 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Merck KGaA at JPMorgan Healthcare Conference Transcript

By GuruFocus Research 02-14-2024

Q3 2024 Merck KGaA Earnings Call Transcript

By GuruFocus News 11-15-2024

Merck KGaA Capital Markets Day Transcript

By GuruFocus Research 02-14-2024

Q3 2023 Merck KGaA Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2023 Merck KGaA Earnings Press Conference Transcript

By GuruFocus Research 03-08-2024